Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC: a Randomized Controlled Phase III Clinical Study

NCT06672133 is registered in ClinicalTrials.gov with Jinming Yu as lead sponsor.

NCT NCT06672133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06672133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC: a Randomized Controlled Phase III Clinical Study
Lead sponsor
Jinming Yu
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 31, 2024
Completion date
December 31, 2029
Enrollment
524 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage lung small cell carcinoma